ITC Nexus, headquartered in Piscataway, NJ, is a leading manufacturer of point-of-care diagnostic products. The Company is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and related chemistries in hospitals, physician offices, and in patient homes. The Company’s lead product, the Hemochron Reader, provides near-patient monitoring of a patient’s blood clotting factors and is used by physicians during critical cardiovascular procedures.
In 2010, Warburg Pincus formed ITC Nexus through the acquisition of ITC from Thoratec and ITC’s subsequent merger with Nexus Dx. ITC Nexus will serve as a platform for a broader roll-up strategy targeting the $4.4 billion point-of-care diagnostics industry.
Back to Previous Page